Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
| Autor: | Agarwal, Neeraj, Tangen, Catherine M., Hussain, Maha H.A., Gupta, Shilpa, Plets, Melissa, Lara, Primo N., Harzstark, Andrea L., Twardowski, Przemyslaw W., Paller, Channing J., Zylla, Dylan, Zibelman, Matthew R., Levine, Ellis, Roth, Bruce J., Goldkorn, Amir, Vaena, Daniel A., Kohli, Manish, Crispino, Tony, Vogelzang, Nicholas J., Thompson Jr, Ian M., Quinn, David I. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 10/1/2022, Vol. 40 Issue 28, p3301-3309, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|